Patent Yard Sign in
Expired European patentEurope

THE USE OF ESTRADIOL DERIVATIVES FOR TREATING SIDE-EFFECTS DURING AND/OR AFTER GnRHa THERAPY

EP 1066041 B1 · Applicant: Jenapharm GmbH & Co. KG

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed February 10, 1999 and granted November 9, 2005. A European patent lasts at most 20 years from filing, so its term ended February 10, 2019.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by August 10, 2024.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledFebruary 10, 1999
PublishedJanuary 10, 2001
GrantedNovember 9, 2005
Term endedFebruary 10, 2019
Application numberEP 99907318
Classification (CPC)A61P43/00 +2 more

Timeline

Timeline From EPO dates

2000200220042006200820102012201420162018Application filedFeb 10, 1999PublishedJan 10, 2001Patent grantedNov 9, 2005Term endedFeb 10, 2019

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.